Inhibition of intraocular proliferation by homoharringtonine

An experimental study
  • Li Junping
  • Hu Chunzhi
  • Zeng Shuiqing
  • Ren Jianming
  • Wei Houren
Laboratory Investigations

Abstract

Homoharringtonine, an alkaloid indigenous to China, was studied for its effect on fibroblast growth in cell culture and on intraocular proliferation produced in rabbits by injecting homologous fibroblasts into the vitreous. The results demonstrate that homoharringtonine reduced the cell growth by 50% at a concentration of 0.005 mg/l in vitro, significantly inhibited vitreous proliferation, and prevented the occurrence of retinal detachment in vivo. Light and electron microscopy revealed no ocular toxicity in drug-treated eyes. Homoharringtonine may be of considerable value in the prevention and treatment of intraocular proliferation in patients.

Keywords

Public Health Microscopy Electron Microscopy Toxicity Cell Culture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Avni I, Belkin M, Hereberg A, Blumenthal M (1984) Intravitreal 5-fluorouracil in the prevention of post-traumatic vitreous proliferation. Ophthalmologica 188:5–8Google Scholar
  2. 2.
    Binder S, Riss B, Skorpik C, Kulnig W (1983) Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil. Graefe's Arch Clin Exp Ophthalmol 221: 126–129Google Scholar
  3. 3.
    Blumenkranz MS, Claflin A, Hajek AS (1984) Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol 102:598–607Google Scholar
  4. 4.
    Bockxmeer FM van, Martin CE, Constable IJ (1985) Models for assessing scar tissue inhibitors. Retina 5:47–60Google Scholar
  5. 5.
    Bockxmeer FM van, Martin CE, Thompson DE, Constable IJ (1985) Taxol for the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:1140–1147Google Scholar
  6. 6.
    Faulborn J, Topping TM (1978) proliferations in the vitreous cavity after perforating injuries. A histopathological study. Graefe's Arch Clin Exp Ophthalmol 205:157–166Google Scholar
  7. 7.
    Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing (1979) Chemical, pharmacological and clinical studies on the antitumor active principle ofCephalotaxus hainanensis Li. Chin J Oncol 1: 176–181 (in Chinese)Google Scholar
  8. 8.
    Tano Y, Chandler D, Machemer R (1980) Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 90:810–816Google Scholar
  9. 9.
    Wiedemann P, Kirmani M, Sorgente N, Ryan SJ (1983) Control of experimental massive periretinal proliferation by daunomycin: dose-response relation. Graefe's Arch Clin Exp Ophthalmol 220:233–235Google Scholar
  10. 10.
    Wiedemann P, Sorgente N, Bekhor C, Patterson R, Tran T, Ryan SJ (1985) Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:719–725Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Li Junping
    • 1
  • Hu Chunzhi
    • 1
  • Zeng Shuiqing
    • 1
  • Ren Jianming
    • 1
  • Wei Houren
    • 1
  1. 1.Department of OphthalmologyUnion Hospital, Tongji Medical UniversityWuhanPeople's Republic of China

Personalised recommendations